We aim to address the challenges of frailty, declining birthrate, and cancer through the application of hybrid medicine

Our approach combines advanced medicine and traditional medicine, leveraging various intellectual property developed through hybrid medicine. We are working on the social implementation of a new form of hybrid medicine to solve the challenges of frailty, a declining birthrate, and cancer in a super-aged society. Currently, Japan is facing the issues of frailty, a declining birthrate, and an increasing number of cancer patients. In our efforts, we are developing a novel frailty evaluation method called the Japan Frailty Scale (JFS). We are also investigating the molecular mechanisms and building clinical evidence to demonstrate the anti-frailty effects of Go-sha-jinki-Gan (GJG). Additionally, the remarkable clinical outcomes of ketogenic diet for cancer patients have garnered significant attention. As a common mechanism for these problems, we are focused on developing methods to evaluate and enhance resilience.

Principal Investigator